Omthera Pharmaceuticals Patents – Insights & Stats (Updated 2024)

Omthera Pharmaceuticals has a total of 113 patents globally, out of which 50 have been granted. Of these 113 patents, more than 30% patents are active. The United States of America is where Omthera Pharmaceuticals has filed the maximum number of patents, followed by Hong Kong (S.A.R.) and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Omthera Pharmaceuticals.

Omthera Pharmaceuticals was founded in 2008. Omthera Pharmaceuticals develops drugs to treat lipid disorders, specifically dyslipidemia, which involves high triglycerides and a higher risk of cardiovascular disease. Their drugs help healthcare providers improve patient health.

Do read about some of the most popular patents of Omthera Pharmaceuticals which have been covered by us in this article and also you can find Omthera Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Omthera Pharmaceuticals patent portfolio.

How many patents does Omthera Pharmaceuticals have?

Omthera Pharmaceuticals has a total of 113 patents globally. These patents belong to 12 unique patent families. Out of 113 patents, 35 patents are active.

How Many Patents did Omthera Pharmaceuticals File Every Year?

Omthera Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantOmthera Pharmaceuticals Applications FiledOmthera Pharmaceuticals Patents Granted
20208
2019411
2018419
201754
2016154
201593
2014101
201356
201210

How many Omthera Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Omthera Pharmaceuticals Patent Portfolio

How Many Patents did Omthera Pharmaceuticals File in Different Countries?

Omthera Pharmaceuticals Worldwide Patent Filing

Countries in which Omthera Pharmaceuticals Filed Patents

CountryPatent
United States of America12
Hong Kong (S.A.R.)9
China7
Japan7
Europe (EPO)6
Korea (South)5
Israel4
Australia3
New Zealand3
Mexico2
Canada2
Philippines2
India2
Singapore2
South Africa2
Malaysia2
Chile2
Brazil1
Estonia1
Portugal1
Germany1
Spain1
Austria1
Ecuador1
Hungary1
Saudi Arabia1
Costa Rica1
Slovenia1
Indonesia1
Thailand1
Croatia1
Peru1
Argentina1
Poland1
Kazakhstan1
Russian Federation1
Brunei1
Serbia1
Viet Nam1
Slovakia1
Cyprus1
Eurasian Patent Organization1
Malta1
Taiwan1
Denmark1
Ukraine1
Dominican Republic1
Colombia1
Norway1
Lithuania1

Where are Research Centers of Omthera Pharmaceuticals Patents Located?

R&D Centres of Omthera Pharmaceuticals

10 Best Omthera Pharmaceuticals Patents

US20130095179A1 is the most popular patent in the Omthera Pharmaceuticals portfolio. It has received 116 citations so far from companies like Amarin Pharmaceuticals Ireland Limited, Matinas Biopharma, Evonik Technochemie.

Below is the list of 10 most cited patents of Omthera Pharmaceuticals:

Publication NumberCitation Count
US20130095179A1116
US20130295173A1115
WO2013103902A132
WO2013169797A121
US9050308B214
WO2013040507A111
US9050309B28
WO2016130417A17
WO2013059669A16
CN103957903A4

What are Omthera Pharmaceuticals key innovation segments?

What Technologies are Covered by Omthera Pharmaceuticals?

The chart below distributes patents filed by Omthera Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Omthera Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Omthera Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Omthera Pharmaceuticals?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.